5 Best High Risk High Reward Stocks To Buy Now

2. Xenon Pharmaceuticals Inc. (NASDAQ:XENE)

Number of Hedge Fund Investors In Q2 2023: 41

Latest P/S Ratio: 14,650

Xenon Pharmaceuticals Inc. (NASDAQ:XENE) is a Canadian biotechnology company that develops treatments for nervous system disorders such as epilepsy. Its shares are rated Strong Buy on average with Wedbush and Cantor Fitzgerald maintaining Outperform and Overweight ratings in August 2023.

As June 2023 came to an end, 41 among the 910 hedge funds part of Insider Monkey’s research had invested in Xenon Pharmaceuticals Inc. (NASDAQ:XENE). Kurt Von Emster’s VenBio Select Advisor is the company’s biggest stakeholder courtesy of its $188 million stake.

Follow Xenon Pharmaceuticals Inc. (NASDAQ:XENE)